Digital Pathology Market Size & Forecast Report - 2025 to 2030

The global digital pathology market size was valued at over USD 1 billion in 2024 and expected to grow at a significant CAGR of around 9% during the forecast period from 2025 to 2030. The increasing demand for diagnosis tools coupled with the rising prevalence of chronic diseases around the world is a major factor to drive the market growth. Furthermore, the increasing number of cancer cases globally is further anticipated to boost the market growth. According to the information shared by NIH, it is estimated that 1,806,590 new cases were diagnosed as cancer in the United States in 2020. Moreover, the growing technological advancement in the field is anticipated to fuel the market in the near upcoming years.

Market Snapshot:

Emerging Trends Shaping the Digital Pathology Market Growth:

The global digital pathology market is undergoing rapid transformation driven by the increasing adoption of advanced imaging technologies and artificial intelligence (AI) in diagnostic workflows. One of the key trends is the integration of AI and machine learning algorithms for image analysis, which enables pathologists to detect patterns, quantify biomarkers, and diagnose diseases with higher accuracy and efficiency. The growing implementation of whole slide imaging (WSI) and cloud-based pathology solutions is further enhancing remote collaboration and telepathology, allowing experts to access and analyze digital slides from anywhere. This trend has gained particular momentum post-pandemic, as laboratories and healthcare institutions increasingly prioritize digital transformation and automation.

Another major trend is the rising demand for personalized medicine and precision diagnostics, which is fueling the use of digital pathology in oncology and genomics research. Pharmaceutical and biotechnology companies are leveraging digital pathology platforms for drug discovery, biomarker validation, and clinical trials, streamlining R&D processes and improving data management. Additionally, advancements in image storage, interoperability, and data analytics are enabling seamless integration with laboratory information systems (LIS) and electronic health records (EHRs). As healthcare systems move toward data-driven decision-making, the adoption of scalable, AI-enabled digital pathology platforms is expected to continue accelerating globally.

Digital Pathology Market Key Drivers:

• Advancements in Technology: Technological advancements in imaging, data storage, and telecommunication have revolutionized the field of pathology. Digital pathology leverages digital imaging systems, high-resolution scanners, and image analysis software to capture, store, and analyze pathology slides. These technological advancements enable faster and more efficient workflows, improved accuracy, and enhanced collaboration among pathologists, driving the adoption of digital pathology solutions.
• Increasing Need for Efficient and Integrated Healthcare Systems: Healthcare systems worldwide are under pressure to improve efficiency, reduce costs, and enhance patient care. Digital pathology offers several benefits in this regard, such as streamlined workflows, remote access to pathology slides, efficient consultation and second opinion processes, and integration with electronic health record (EHR) systems. These benefits lead to improved operational efficiency and enhanced patient outcomes, driving the adoption of digital pathology solutions.
• Rising Prevalence of Cancer and Chronic Diseases: The global burden of cancer and chronic diseases is increasing, necessitating accurate and timely diagnosis. Digital pathology enables pathologists to access and analyze pathology slides remotely, facilitating faster and more accurate diagnoses. It also supports the implementation of image-based quantitative analysis techniques for predictive and prognostic assessments. As the demand for efficient diagnostic solutions grows, digital pathology becomes a crucial tool in the fight against cancer and chronic diseases.
• Shortage of Pathologists: Many regions face a shortage of pathologists, leading to increased workload and delayed diagnoses. Digital pathology solutions address this challenge by enabling remote access and collaboration, allowing pathologists to work efficiently across different locations. Telepathology, enabled by digital pathology, allows pathologists to provide expert consultations and second opinions, overcoming geographical barriers and optimizing resources.
• Demand for Integrated Diagnostics and Personalized Medicine: The shift towards integrated diagnostics and personalized medicine requires the integration of multiple data sources, including pathology. Digital pathology provides a platform for integrating pathology images with clinical data, genomics, and other diagnostic modalities. This integration enables comprehensive analysis, precise diagnostics, and personalized treatment decisions, supporting the advancement of integrated diagnostics and personalized medicine.
• Research and Drug Development: Digital pathology plays a crucial role in research and drug development, especially in fields like oncology and pharmaceuticals. Digital pathology enables efficient analysis of tissue samples, histopathological evaluation, and biomarker discovery. It supports research studies, clinical trials, and the development of targeted therapies. The growing focus on precision medicine and innovative drug discovery drives the adoption of digital pathology in research and drug development processes.
• Cost and Time Savings: Digital pathology offers significant cost and time savings compared to traditional glass slide-based pathology. It eliminates the need for physical slide transportation, reduces slide preparation time, and enables remote access to pathology images for consultation and analysis. These time and cost savings contribute to the adoption of digital pathology, especially in high-volume laboratories and healthcare systems.
• Regulatory Support: Regulatory bodies and healthcare organizations have recognized the benefits of digital pathology and are providing support and guidelines for its adoption. For example, the U.S. Food and Drug Administration (FDA) has approved digital pathology systems for primary diagnosis. Such regulatory support boosts confidence in digital pathology solutions and encourages their implementation.

Future Opportunities Reshaping the Digital Pathology Market’s Evolution:

The global digital pathology market presents significant opportunities driven by the growing need for faster, more accurate, and data-driven diagnostic solutions. The rising global burden of cancer and chronic diseases is pushing healthcare systems to adopt digital pathology for enhanced diagnostic accuracy and workflow efficiency. This creates strong potential for companies offering AI-powered pathology platforms, image analysis software, and integrated laboratory solutions. The expansion of telepathology and remote diagnostics—particularly in underserved regions—offers another major opportunity, as it allows healthcare providers to overcome the shortage of skilled pathologists and deliver timely diagnoses through cloud-based collaboration tools.

Moreover, there are emerging opportunities in pharmaceutical research, drug development, and precision medicine. Digital pathology is increasingly being used in preclinical and clinical research for biomarker discovery, toxicology studies, and patient stratification, helping accelerate drug approvals. Governments and healthcare organizations are also investing heavily in digital health infrastructure and interoperability standards, opening doors for vendors providing scalable, regulatory-compliant platforms. As AI and big data analytics continue to evolve, the integration of digital pathology with genomics and other diagnostic modalities will further expand its role in personalized healthcare—creating vast opportunities for innovation, partnerships, and market expansion.

Market Segments Insights:

The global digital pathology market is bifurcated into product, application, end-use, and geography. On the basis of product, the market is further segmented into software, device, and storage system. The device segment dominated the global market in 2024 and estimated to hold the largest revenue share of over half of the market. The growth in research and development activities in the academic sector is a primary factor to drive the segment growth. Furthermore, the significant use of scanners in pathology and increasing R&D activities are further expected to boost the segment growth over the forecast period.

On the basis of end-use, the market is fragmented into hospitals, biotech & pharma companies, diagnostic labs, and academic & research institutes. The hospitals segment dominated the global digital pathology market in 2024 and estimated to hold the largest market share of over one-third percent of the market. The increasing adoption of advanced diagnosis devices is a major factor to drive the segment growth. Furthermore, the increasing adoption of digital scanning techniques and better patient outcomes is further anticipated to fuel the segment growth.

The digital pathology comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Digital Pathology Market Key Segmentation:

By Product:

• Software
• Device
• Storage System

By Application:

• Drug Discovery & Development
• Academic research
• Disease Diagnosis

By End-Use:

• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage: North America Dominated the Digital Pathology Market

Geographically, the digital pathology market report comprises dedicated sections centering on the regional market revenue and trends. The market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years along with forecasts for the period from 2025 – 2030.

Competitive Assessment

Some of the major market players operating in the global digital pathology market are Hamamatsu Photonics, Inc., Danaher, Olympus Corporation, Koninklijke Philips N.V., and F. Hoffmann-La Roche Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Hamamatsu Photonics, Inc.
• Danaher
• Olympus Corporation
• Koninklijke Philips N.V.
• Hoffmann-La Roche Ltd.
• Inspirata, Inc.
• Mikroscan Technologies
• Huron Digital Pathology
• Visiopharm A/S
• ContextVision AB.

Key Questions Answered by Digital Pathology Market Report

• Global digital pathology market forecasts from 2025-2030
• Regional digital pathology market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the aforementioned regions
• Digital pathology submarket forecasts from 2025-2030 cover the market by product, by application, by end-use, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market